| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26878-100ul | |||
| BSA Free | NBP3-26878-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-42385 | |||
| BSA Free | NBP2-42385-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-88670-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70722 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74495 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41185-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52462-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37267-0.025ml | |||
![Western Blot: Fibrinogen Antibody [NBP2-80414] - Analysis of Fibrinogen on mouse bone marrow and human kidney tissue lysates using anti-Fibrinogen antibody at 1/500 dilution.](http://images.novusbio.com/fullsize/Fibrinogen-Antibody-Western-Blot-NBP2-80414-img0004.jpg "Western Blot: Fibrinogen Antibody [NBP2-80414] - Analysis of Fibrinogen on mouse bone marrow and human kidney tissue lysates using anti-Fibrinogen antibody at 1/500 dilution.")
![Immunocytochemistry/Immunofluorescence: Fibrinogen Antibody [NBP2-80414] - Staining Fibrinogen in A549 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Fibrinogen-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-80414-img0003.jpg)
![Flow Cytometry: Fibrinogen Antibody [NBP2-80414] - Analysis of NIH-3T3 cells with Fibrinogen antibody at 1/100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.](http://images.novusbio.com/fullsize/Fibrinogen-Antibody-Flow-Cytometry-NBP2-80414-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: Fibrinogen Antibody [NBP2-80414] - Staining Fibrinogen in NIH-3T3 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/Fibrinogen-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-80414-img0002.jpg)
![Immunohistochemistry-Paraffin: FGF R2 Antibody [NBP1-88670] - Staining of human prostate shows moderate membranous positivity in glandular cells and weak cytoplasmic staining of smooth muscle cells.](http://images.novusbio.com/fullsize/FGF-R2-Antibody-Immunohistochemistry-Paraffin-NBP1-88670-img0004.jpg "Immunohistochemistry-Paraffin: FGF R2 Antibody [NBP1-88670] - Staining of human prostate shows moderate membranous positivity in glandular cells and weak cytoplasmic staining of smooth muscle cells.")
![Immunohistochemistry-Paraffin: FGF R2 Antibody [NBP1-88670] - Staining of human Fallopian tube shows moderate membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/FGF-R2-Antibody-Immunohistochemistry-Paraffin-NBP1-88670-img0002.jpg)
![Immunohistochemistry-Paraffin: FGF R2 Antibody [NBP1-88670] - Staining of human endometrium shows moderate membranous positivity in glandular cells.](http://images.novusbio.com/fullsize/FGF-R2-Antibody-Immunohistochemistry-Paraffin-NBP1-88670-img0003.jpg)
![Immunohistochemistry-Paraffin: FGF R2 Antibody [NBP1-88670] - Staining of human skeletal muscle shows low positivity as expected.](http://images.novusbio.com/fullsize/FGF-R2-Antibody-Immunohistochemistry-Paraffin-NBP1-88670-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: CTGF/CCN2 Antibody [NBP2-69990] - Immunofluorescence analysis of paraformaldehyde fixed NIH3T3 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic/membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-69990-img0004.jpg "Immunocytochemistry/Immunofluorescence: CTGF/CCN2 Antibody [NBP2-69990] - Immunofluorescence analysis of paraformaldehyde fixed NIH3T3 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic/membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).")
![Immunohistochemistry: CTGF/CCN2 Antibody [NBP2-69990] - (6ug/ml) staining of paraffin embedded Rat Liver. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunohistochemistry-NBP2-69990-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CTGF/CCN2 Antibody [NBP2-69990] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic/membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-69990-img0003.jpg)
![Control: CTGF/CCN2 Antibody [NBP2-69990] - Negative Control showing staining of paraffin embedded Rat Liver, with no primary antibody.](http://images.novusbio.com/fullsize/CTGF-CCN2-Antibody-Control-NBP2-69990-img0001.jpg)
![Western Blot: NARG1 Antibody [NBP1-21387] - Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 mcg) and mouse NIH3T3 (M; 50mcg) cells. NBP1-21387 used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate.](http://images.novusbio.com/fullsize/NARG1-Antibody-Western-Blot-NBP1-21387-img0002.jpg "Western Blot: NARG1 Antibody [NBP1-21387] - Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 mcg) and mouse NIH3T3 (M; 50mcg) cells. NBP1-21387 used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate.")
![Immunocytochemistry/Immunofluorescence: NARG1 Antibody [NBP1-21387] - Human colon carcinoma](http://images.novusbio.com/fullsize/NARG1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-21387-img0003.jpg)
![Immunohistochemistry-Paraffin: NARG1 Antibody [NBP1-21387] - Colon carcinoma used at a dilution of 1:80.](http://images.novusbio.com/fullsize/NARG1-Antibody-Immunohistochemistry-Paraffin-NBP1-21387-img0005.jpg)
![Western Blot: FGFR3 Antibody (OTI1B10) [NBP2-45716] - Equivalent amounts of cell lysates (10 ug per lane) of wild-type 293T cells and FGFR3-Knockout 293T cells were separated by SDS-PAGE and immunoblotted with anti-FGFR3 monoclonal antibody TA801078. Then the blotted membrane was stripped and reprobed with anti-b-actin antibody as a loading control (1:500).](http://images.novusbio.com/fullsize/FGFR3-Antibody-OTI1B10-Western-Blot-NBP2-45716-img0003.jpg "<b>Genetic Strategies Validation. </b>Western Blot: FGFR3 Antibody (OTI1B10) [NBP2-45716] - Equivalent amounts of cell lysates (10 ug per lane) of wild-type 293T cells and FGFR3-Knockout 293T cells were separated by SDS-PAGE and immunoblotted with anti-FGFR3 monoclonal antibody TA801078. Then the blotted membrane was stripped and reprobed with anti-b-actin antibody as a loading control (1:500).")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: FGFR3 Antibody (OTI1B10) [NBP2-45716] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/FGFR3-Antibody-OTI1B10-Immunohistochemistry-NBP2-45716-img0001.jpg)
![Western Blot: FGFR3 Antibody (OTI1B10) [NBP2-45716] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FGFR3.](http://images.novusbio.com/fullsize/FGFR3-Antibody-OTI1B10-Western-Blot-NBP2-45716-img0002.jpg)
![Western Blot: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TGF-beta 1.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Western-Blot-NBP2-46108-img0004.jpg "Western Blot: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TGF-beta 1.")
![Flow Cytometry: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of SF295 cells, using TGFB1 antibody,(Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Flow-Cytometry-NBP2-46108-img0001.jpg)
![Immunofluorescence: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY TGF-Beta 1.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Immunofluorescence-NBP2-46108-img0002.jpg)
![Immunofluorescence: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Immunofluorescence-NBP2-46108-img0003.jpg)
![Western Blot: Angiogenin Antibody [NBP2-41185] - Angiogenin and EPCs modulation after human stroke and rehabilitation. (A) Infarct tissue and contralateral brain homogenates (less than or equal 4 days) were analyzed by western blot for angiogenin (n = 3). The densitometry results (arbitrary units) were corrected by the actin load and bar graph showing the angiogenin fold-change of the ipsilateral vs. contralateral signal. Image collected and cropped by CiteAb from the following publication (//www.frontiersin.org/article/10.3389/fneur.2018.00508/full) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Angiogenin-Antibody-Western-Blot-NBP2-41185-img0003.jpg "Western Blot: Angiogenin Antibody [NBP2-41185] - Angiogenin and EPCs modulation after human stroke and rehabilitation. (A) Infarct tissue and contralateral brain homogenates (less than or equal 4 days) were analyzed by western blot for angiogenin (n = 3). The densitometry results (arbitrary units) were corrected by the actin load and bar graph showing the angiogenin fold-change of the ipsilateral vs. contralateral signal. Image collected and cropped by CiteAb from the following publication (//www.frontiersin.org/article/10.3389/fneur.2018.00508/full) licensed under a CC-BY license.")
![Western Blot: Angiogenin Antibody [NBP2-41185] - Analysis of ANG in rat liver tissue lysate with Ang antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/Angiogenin-Antibody-Western-Blot-NBP2-41185-img0001.jpg)
![Western Blot: Angiogenin Antibody - BSA Free [NBP2-41185] - Angiogenin & EPCs modulation after mouse cerebral ischemia & rehabilitation. (A) Infarct & contralateral mouse brain cortical homogenates were analyzed by western blot to quantify angiogenin protein (n = 3). The densitometry results (arbitrary units) were corrected by the actin load & are represented as fold-change of the ipsilateral vs. contralateral signal. (B) Bar graphs representing the angiogenin RNA expression in the ischemic & contralateral cortex in the short-term (n = 6–9) & long-term rehabilitation groups (n = 5), **p < 0.01, *p < 0.05 as indicated by horizontal lines. Non-RHB ipsilateral short-term vs. long-term; &p < 0.05. Pasta Matrix & Treadmill contralateral short-term vs. long-term; †p < 0.05. (C) Bar graphs showing the percentage of the Angiogenin+ area in the pasta matrix long-term rehabilitation group (n = 6) together with images of representative brains with inserts showing co-localization of angiogenin in neurons: scale bar represents 100 μm. *p < 0.05. (D) Graph showing the plasma angiogenin temporal profile of No-RHB, Pasta matrix, & Treadmill groups (n = 3–4/group); *p < 0.05. (E) Box plots representing the cell density of EPCs from the three different RHB groups (n = 3–5 short-term; n = 6–7 long-term) & representative images of the primary cultures; scale bar represents 250 μm. Data are represented as the mean ± SEM or as box plots indicating the median (IQR). IP, ipsilateral; CL, contralateral; ST-R, short-term rehabilitation; LT-R, long-term rehabilitation; No-RHB, No-Rehabilitation; EPC, endothelial progenitor cells. Image collected & cropped by CiteAb from the following publication (//www.frontiersin.org/article/10.3389/fneur.2018.00508/full), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-41185_rabbit-polyclonal-angiogenin-antibody-31020241612238.jpg)
![Immunohistochemistry: Angiogenin Antibody - BSA Free [NBP2-41185] - Immunofluorescence of Angiogenin in human liver tissue with Angiogenin antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp2-41185_rabbit-polyclonal-angiogenin-antibody-2711202420171783.jpg)
![Western Blot: MEK2 Antibody (OTI1A2) - Azide and BSA Free [NBP2-72647] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MEK2.](http://images.novusbio.com/fullsize/MEK2-Antibody-OTI1A2-Azide-and-BSA-Free-Western-Blot-NBP2-72647-img0002.jpg "Western Blot: MEK2 Antibody (OTI1A2) - Azide and BSA Free [NBP2-72647] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MEK2.")
![Immunocytochemistry/Immunofluorescence: MEK2 Antibody (OTI1A2) - Azide and BSA Free [NBP2-72647] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY MEK2.](http://images.novusbio.com/fullsize/MEK2-Antibody-OTI1A2-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-72647-img0003.jpg)
![Western Blot: MEK2 Antibody (OTI1A2) - Azide and BSA Free [NBP2-72647] - Analysis of extracts (35ug) from 9 different cell lines (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](http://images.novusbio.com/fullsize/MEK2-Antibody-OTI1A2-Azide-and-BSA-Free-Western-Blot-NBP2-72647-img0001.jpg)
![Western Blot: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Analysis using ErbB4/Her4 mAb against human ERBB4 (AA: 1159-1308) recombinant protein. (Expected MW is 43.3 kDa).](http://images.novusbio.com/fullsize/ErbB4-Her4-Antibody-5G6B4-Western-Blot-NBP2-52462-img0008.jpg "Western Blot: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Analysis using ErbB4/Her4 mAb against human ERBB4 (AA: 1159-1308) recombinant protein. (Expected MW is 43.3 kDa).")
![Immunohistochemistry-Paraffin: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Analysis of paraffin-embedded cervical cancer tissues using ERBB4 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/ErbB4-Her4-Antibody-5G6B4-Immunohistochemistry-Paraffin-NBP2-52462-img0003.jpg)
![Flow Cytometry: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Analysis of Hela cells using ERBB4 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/ErbB4-Her4-Antibody-5G6B4-Flow-Cytometry-NBP2-52462-img0002.jpg)
![Western Blot: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Analysis using ERBB4 mAb against HEK293 (1) and ERBB4 -hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/ErbB4-Her4-Antibody-5G6B4-Western-Blot-NBP2-52462-img0006.jpg)
![ELISA: ErbB4/Her4 Antibody (5G6B4) [NBP2-52462] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/ErbB4-Her4-Antibody-5G6B4-ELISA-NBP2-52462-img0001.jpg)
![Western Blot: Tie-1 Antibody (8D12D2) [NBP2-37267] - Analysis using TIE-1 mAb against (1) HEK293 and (2) TIE-1 (AA: 385-607)-hIgGFc transfected HEK293 cell lysate.](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-Western-Blot-NBP2-37267-img0006.jpg "Western Blot: Tie-1 Antibody (8D12D2) [NBP2-37267] - Analysis using TIE-1 mAb against (1) HEK293 and (2) TIE-1 (AA: 385-607)-hIgGFc transfected HEK293 cell lysate.")
![Immunohistochemistry: Tie-1 Antibody (8D12D2) [NBP2-37267] - Immunohistochemical analysis of paraffin-embedded kidney tissues using TIE1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-Immunohistochemistry-NBP2-37267-img0005.jpg)
![Western Blot: Tie-1 Antibody (8D12D2) [NBP2-37267] - Western blot analysis using TIE1 mAb against human TIE1 (AA: 385-607) recombinant protein. (Expected MW is 50.6 kDa)](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-Western-Blot-NBP2-37267-img0002.jpg)
![Western Blot: Tie-1 Antibody (8D12D2) [NBP2-37267] - Western blot analysis using TIE1 mouse mAb against HepG2 cell lysate.](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-Western-Blot-NBP2-37267-img0003.jpg)
![Immunohistochemistry: Tie-1 Antibody (8D12D2) [NBP2-37267] - Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using TIE1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-Immunohistochemistry-NBP2-37267-img0004.jpg)
![ELISA: Tie-1 Antibody (8D12D2) [NBP2-37267] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Tie-1-Antibody-8D12D2-ELISA-NBP2-37267-img0001.jpg)